Search for: "Pfizer, Inc." Results 1441 - 1460 of 1,513
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 May 2007, 2:42 pm
Of the NAS/STEP report on patent reform, seehttp://ipbiz.blogspot.com/2007/05/mark-up-on-patent-reform-act-of-2007.html**Separately,of the denial of rehearing in Pfizer, Inc. v. [read post]
22 May 2007, 9:52 pm
By Donald Zuhn -- On Monday, the Federal Circuit denied a combined petition for panel rehearing and rehearing en banc filed by Plaintiff-Appellee Pfizer, Inc. [read post]
17 May 2007, 9:09 am
Pfizer, Inc., 2004 WL 2191804, at *6 (S.D. [read post]
16 May 2007, 10:34 am
Wyeth (040604229, Philadelphia Court of Common Pleas), as reported by Jef Feeley and Sophia Pearson in their Bloomberg.com article:A Pfizer Inc. unit failed to properly warn a New Jersey woman about the cancer risk of its hormone-replacement drug Provera and should pay $1.5 million in damages, jurors said in the first trial over the menopause treatment. [read post]
10 May 2007, 1:25 am
Pfizer, Inc., however, the Sixth Circuit disagreed, and in the proceed provided some cautionary language for employers in making representations during the hiring process. [read post]
9 May 2007, 1:34 pm
"The Draft continues to use the "carve at the joint" metaphor from In re Rhone-Poulenc Rorer, Inc., 51 F.3d 1293 (7th Cir. 1995) (e.g., §2.03, comment c & Reporters' Notes) to justify widespread issue certification, even though Rhone-Poulenc used that phrase not in support of issue certification, but to caution against bifurcating a trial in a way that would have different juries examining the same issue in violation of the Seventh Amendment. 51 F.3d… [read post]
8 May 2007, 5:33 am
Pfizer, Inc. (6th Cir. 5/8/07) [pdf] is a good example of the situations that occur and a reminder that while ERISA preemption is about as broad as it gets, it too has its limits.The facts are simple and straight forward (they always are when, as here, the court must accept plaintiff's pleadings as true). [read post]
27 Apr 2007, 12:04 pm
By Hal WegnerBefore an overflow hearing room on an internationally available web broadcast, Chairman Howard Berman of the House Judiciary Subcommittee relevant to patents hosted a most informative and candid hearing yesterday afternoon joined by roughly ten of his committee colleagues, including Rep. [read post]
26 Apr 2007, 9:24 pm
By Donald Zuhn -- Bristol-Myers Squibb Co. and Pfizer Inc. announced today that the companies will be entering into two separate collaborations. [read post]
15 Apr 2007, 1:43 pm
Public Citizen is requesting that the FDA order Pfizer, Inc. to withdraw its new television commercial for Celebrex. [read post]
12 Apr 2007, 10:30 pm
Two subsidiaries of Pfizer Inc. have agreed to pay fines totaling $34.7 million for offering a kickback to recommend company drugs and for illegally promoting the human growth hormone product Genotropin for nonapproved uses, according to federal prosecutors. [read post]
10 Apr 2007, 10:16 am
Here's an excerpt:A consumer advocacy group called on the government Monday to order Pfizer Inc. to stop running a television ad for... [read post]
9 Apr 2007, 7:30 am
Robert Temple, director of the FDA's Offices of Drug Evaluation, said his agency is "not particularly worried" about Dostinex:The two studies, published in January in the New England Journal of Medicine, also tied another Parkinson's drug, Pfizer Inc.'s Dostinex, or cabergoline, to heart-valve problems. [read post]
4 Apr 2007, 6:00 am
Reply Brief on the Merits (filed 02/22/07) Amicus Curiae Brief of Pacific Legal Foundation (submitted 03/23/07; filed 04/04/07) Amicus Curiae Brief of Consumer Attorneys of California (submitted 03/26/07) Amicus Curiae Brief of Pfizer, Inc. [read post]